Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      MA02.06 - Discussant

      11:02 - 11:12  |  Presenter: Yuko Minami

      • Abstract

      Loading...

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      ES07.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression

      12:02 - 12:14  |  Presenter: Trever Bivona

      • Abstract

      Loading...

    • +

      ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)

      12:14 - 12:26  |  Presenter: Sandra Ortiz-Cuaran

      • Abstract

      Loading...

    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics

      12:38 - 12:50  |  Presenter: Helmut Popper

      • Abstract

      Loading...

    • +

      ES07.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    MA12 - Pathology: Tumour Diagnostics

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Pathology
    • +

      MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth

      11:12 - 11:17  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...